Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies
Clinical and Experimental Medicine · 03.10.2024 · 24 (1)
DOI: 10.1007/s10238-024-01501-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Medicine, online erschienen am 03.10.2024. Verfasst von Joanna Ciepła und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Wy…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Tumor Hypoxia, Neoplasms. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki.
Abstract (Originalsprache)
Hypoxia is one of the defining characteristics of the tumor microenvironment (TME) in solid cancers. It has a major impact on the growth and spread of malignant cells as well as their resistance to common treatments like radiation and chemotherapy. Here, we explore the complex functions of hypoxia in the TME and investigate its effects on angiogenesis, immunological evasion, and cancer cell metabolism. For prognostic and therapeutic reasons, hypoxia identification is critical, and recent developments in imaging and molecular methods have enhanced our capacity to precisely locate underoxygenated areas inside tumors. Furthermore, targeted therapies that take advantage of hypoxia provide a potential new direction in the treatment of cancer. Therapeutic approaches that specifically target hypoxic conditions in tumors without causing adverse effects are being led by hypoxia-targeted nanocarriers and hypoxia-activated prodrugs (HAPs). This review provides an extensive overview of this dynamic and clinically significant area of oncology research by synthesizing current knowledge about the mechanisms of hypoxia in cancer, highlighting state-of-the-art detection methodologies, and assessing the potential and efficacy of hypoxia-targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Wybrzeże Armii Krajowej Street 15, 44-102, Gliwice, Poland.
- Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Wybrzeże Armii Krajowej Street 15, 44-102, Gliwice, Poland. Ryszard.Smol…
Förderung
- Narodowe Centrum Nauki
Zitieren
APA
Ciepła, J., & Smolarczyk, R. (2024). Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies. Clinical and Experimental Medicine, 24(1). https://doi.org/10.1007/s10238-024-01501-1
Vancouver
Ciepła J, Smolarczyk R. Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies. Clinical and Experimental Medicine. 2024;24(1). doi:10.1007/s10238-024-01501-1
BibTeX
@article{Ciepa2024,
author = {Ciepła, Joanna and Smolarczyk, Ryszard},
title = {Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies},
journal = {Clinical and Experimental Medicine},
year = {2024},
volume = {24},
number = {1},
doi = {10.1007/s10238-024-01501-1}
}
EUVIMED